University of Tennessee’s pharmacy school receives $4.5 million donation
MEMPHIS, Tenn. A pharmacy school in the Volunteer State has received a $4.5 million donation from the Plough Foundation.
The University of Tennessee Health Science Center College of Pharmacy in Memphis, Tenn., received the donation to establish the Plough Center for Sterile Drug Delivery Systems, a research center of more than 5,800 sq. ft. in the UT College of Pharmacy building, currently under construction. The Plough Center will be used to teach and train pharmacists, pharmaceutical scientists and pharmaceutical and biotech industry employees.
The Plough Foundation takes its name from Abe Plough, a Memphis-area entrepreneur who in 1908 founded the drug company that would merge with Schering Corp. in 1971 to become Schering-Plough Corp., which itself was recently acquired by Merck & Co.
“We appreciate this extremely generous grant and the synergistic partnership that it symbolizes,” UT College of Pharmacy dean Dick Gourley said in a statement. “This funding will allow both of our organizations to compound the impact of our accomplishments for the benefit of our students, industry professionals and regulators, and the greater Memphis community.”
Hooper Holmes launches Diabetes Know Now!
BASKING RIDGE, N.J. Hooper Holmes announced a new, interactive health-screening platform that can efficiently identify people with undiagnosed diabetes or prediabetes.
Diabetes Know Now! is an innovative “screen before the screen” that combines an online diabetes risk assessment with an at-home diabetes laboratory test. Users complete an online diabetes risk assessment that places them in three risk categories — high, moderate or low. Users at high risk for having or developing diabetes then are offered an at-home test kit that allows them to collect their own blood sample and return it to Hooper Holmes’ Heritage Labs. Heritage Labs then completes a Hemoglobin A1c test, which the American Diabetes Association now recommends as the screening test for diabetes, and returns the results electronically to the secure Diabetes Know Now! account established by the user.
To commemorate the launch, Hooper Holmes made Diabetes Know Now! available to its employees in line with Diabetes Alert Day.
“Prior to Diabetes Know Now! there was not an effective and efficient way to target diabetes screenings,” said Chris Behling, president of Hooper Holmes health and wellness. “Now, instead of having to complete blood tests on an entire population, we can improve the efficiency and effectiveness of our customers’ programs, by only needing to complete blood testing on a targeted group who are at the highest risk for having or developing diabetes.”
Biogen Idec names billionaire as board member
CAMBRIDGE, Mass. Biogen Idec appointed a nominee of billionaire investor Carl Icahn to its board Monday, the Swiss drug maker announced.
Biogen Idec appointed Icahn Partners nominee Eric Rowinsky and Stephen Sherwin, selected by the company as part of its effort to find new directors, to its board of directors.
On the same day, Bloomberg quoted Icahn as saying that he would like to see Biogen Idec sold to a larger drug maker, on account of its pipeline, and also split into two business units, one for neurology and one for cancer.